MIGUEL
ESTRAVÍS SASTRE
Investigador en el període 2019-2021
Hospital Universitario de Salamanca
Salamanca, EspañaPublicacions en col·laboració amb investigadors/es de Hospital Universitario de Salamanca (10)
2023
-
Correspondence regarding the paper “Laorden D, Zamarrón E, Romero D, Domínguez-Ortega J, Villamañán E, Losantos I, Gayá F, Quirce S, Álvarez-Sala R. Evaluation of FEOS score and super-responder criteria in a real-life cohort treated with anti-IL5/IL5R. Respir. Med. 2023; 211: 107216”
Respiratory Medicine
-
Interleukin 5 Receptor Subunit Alpha Expression as a Potential Biomarker in Patients with Nasal Polyposis
Biomedicines, Vol. 11, Núm. 7
-
Quantitative and qualitative methods of evaluating response to biologics in severe asthma patients: Results from a real-world study
Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 3, pp. 949-951.e2
-
RNY3 modulates cell proliferation and IL13 mRNA levels in a T lymphocyte model: a possible new epigenetic mechanism of IL-13 regulation
Journal of Physiology and Biochemistry, Vol. 79, Núm. 1, pp. 59-69
-
Transcriptomics reveals new regulatory mechanisms involved in benralizumab response
Allergy: European Journal of Allergy and Clinical Immunology
2021
-
Genetics and Epigenetics of Nasal Polyposis: A Systematic Review
Journal of investigational allergology & clinical immunology, Vol. 31, Núm. 3, pp. 196-211
2020
-
Genetics and epigenetics of atopic dermatitis: An updated systematic review
Genes, Vol. 11, Núm. 4
-
Molecular Analysis of IL-5 Receptor Subunit Alpha as a Possible Pharmacogenetic Biomarker in Asthma
Frontiers in Medicine, Vol. 7
2019
-
PTGDR expression is upregulated through retinoic acid receptors (RAR) mechanism in allergy
PLoS ONE, Vol. 14, Núm. 4
-
YRNAs overexpression and potential implications in allergy
World Allergy Organization Journal, Vol. 12, Núm. 8